Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 16;325(11):1037-1038.
doi: 10.1001/jama.2021.2294.

SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities

Affiliations

SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities

Rochelle P Walensky et al. JAMA. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

References

    1. World Health Organization. Weekly epidemiological update—2 February 2021. Accessed February 5, 2021. https://www.who.int/publications/m/item/weekly-epidemiologicalupdate---2...
    1. Faria NR, Claro IM, Candido D, et al. Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings. Virological.org. Published January 12, 2021. Accessed January 31, 2021. https://virological.org/t/genomic-characterisation-of-an-emergent-sars-c...
    1. Horby P, Huntley C, Davies N, et al. NERVTAG note on B.1.1.7 severity. Paper presented at: SAGE meeting report; January 21, 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploa...
    1. Wibmer CK, Ayres F, Hernamus T, et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. BioRxiv. Preprint published online January 19, 2021. doi: 10.1101/2021.01.18.427166 - DOI - PubMed
    1. Wang P, Liu L, Iketani S, et al. Increased resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 to antibody neutralization. BioRxiv. Preprint published online January 26, 2021. doi: 10.1101/2021.01.25.428137 - DOI

Substances